CDK5RAP3 and neoplasm: Taking into consideration that both HSF1 and HSP90 are ones of the factors defining tumor growth and tumor resistance to therapeutics, such knowledge is crucial for a rational development that CDK5RAP3 may be examined as a potential target for anticancer therapy.